Novartis Unit To Appeal German Laxative Ban

Law360, New York (February 7, 2008, 12:00 AM EST) -- Novartis AG subsidiary Hexal AG is planning to appeal a German court’s ruling banning the company from selling its laxative product containing macrogol, a company spokesman said Thursday.

The decision of the Hamburg District Court, which was revealed Monday by European pharmaceutical company Norgine Europe BV, ruled that Hexal and Cassella Med GbmH & Co. KG, a subsidiary of German health care conglomerate Klosterfrau Vertriebs GmbH, were illegally distributing their laxative products as medical devices, when they should have gained approval to market them as medicinal...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.